Aspiriant LLC’s CrowdStrike CRWD Stock Holding History

Aspiriant LLC’s Portfolio CRWD Stock Details CRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-65,900	Closed	-$2.26M	–	206
2020 Q3	$2.26M	Buy	+65,900	New	+$1.92M	0.18%	62

Other funds holding CRWD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

WRCM

Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aspiriant LLC's CRWD Position: Q4 2020 in Review

Aspiriant LLC sold out of CrowdStrike (CRWD) in Q4 2020, closing a stake of 65,900 shares — an estimated $2.26M sold.

Aspiriant LLC first reported a position in CRWD in Q3 2020 and held it in 1 quarter. The position peaked at $2.26M in Q3 2020. 869 funds tracked by Wall St. Rank hold CRWD as of Q4 2020.

Aspiriant LLC reported no remaining CrowdStrike position as of Q4 2020 after selling out during the quarter.
Aspiriant LLC sold 65,900 CrowdStrike shares in Q4 2020, an estimated $2.26M.
Aspiriant LLC first reported a position in CrowdStrike in Q3 2020 and held it in 1 quarter.
Aspiriant LLC's CrowdStrike position peaked at $2.26M in Q3 2020.
869 funds tracked by Wall St. Rank held CrowdStrike as of Q4 2020.

Based on Aspiriant LLC's 13F filing for Q4 2020, filed 1 Feb 2021.